Report overview
The porcine parvovirus inactivated vaccine is used for preventing a porcine parvovirus disease caused by a porcine parvovirus.
This report aims to provide a comprehensive presentation of the global market for Inactivated Porcine Parvovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Porcine Parvovirus Vaccine. This report contains market size and forecasts of Inactivated Porcine Parvovirus Vaccine in global, including the following market information:
Global Inactivated Porcine Parvovirus Vaccine Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Inactivated Porcine Parvovirus Vaccine Market Sales, 2018-2023, 2024-2032, (M Doses)
Global top five Inactivated Porcine Parvovirus Vaccine companies in 2022 (%)
The global Inactivated Porcine Parvovirus Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
<107.0 TCID50/mL Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Inactivated Porcine Parvovirus Vaccine include Merck Animal Health, HIPRA, Zoetis, Ceva, Bioveta, Boehringer Ingelheim, Harbin Pharmaceutical Group, Wuhan Keqian Biology and DHN, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Inactivated Porcine Parvovirus Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inactivated Porcine Parvovirus Vaccine Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine Market Segment Percentages, by Type, 2022 (%)
<107.0 TCID50/mL
?107.0 TCID50/mL
Global Inactivated Porcine Parvovirus Vaccine Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine Market Segment Percentages, by Application, 2022 (%)
Sows
Gilts
Boars
Global Inactivated Porcine Parvovirus Vaccine Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (M Doses)
Global Inactivated Porcine Parvovirus Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inactivated Porcine Parvovirus Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Inactivated Porcine Parvovirus Vaccine revenues share in global market, 2022 (%)
Key companies Inactivated Porcine Parvovirus Vaccine sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Inactivated Porcine Parvovirus Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck Animal Health
HIPRA
Zoetis
Ceva
Bioveta
Boehringer Ingelheim
Harbin Pharmaceutical Group
Wuhan Keqian Biology
DHN
China Animal Husbandy Industry
Qilu Animal Health Products Factorys
Shandong HuaHong Biological Engineering
Shanghai Hile Biological
Liaoning Yikang Biological
Jilin Zhengye Biological Product
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inactivated Porcine Parvovirus Vaccine, market overview.
Chapter 2: Global Inactivated Porcine Parvovirus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Inactivated Porcine Parvovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inactivated Porcine Parvovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inactivated Porcine Parvovirus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
